NA
Niagen Bioscience Inc
NAGE · NASDAQ
$2.99 +0.17% (+$0.01)
1M -6.85%
Market Cap $238.1M
P/E Ratio 14.89x
Div. Yield -
ROE 20.50%
Bulios Fair Price
$3.35
12.0% upside
Trenutna cena
$2.99
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NAGE trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
67 /100
Cheap P/FCF 41.97x
P/E 14.89x
P/B 2.89x
Growth
100 /100
Growing Book val. growth 38.72%
Rev. growth 21.56%
FCF growth N/A
Profitability
54 /100
Moderate Op. margin 6.67%
Gross margin 64.24%
FCF margin 4.40%
Quality
77 /100
Excellent ROA 15.00%
ROIC 8.75%
Asset turnover 1.21x
Debt
100 /100
Low Net debt/EBITDA -3.49x
Debt/Equity 0.03x
Current ratio 6.50x
Stability
36 /100
Moderate EPS volatility 109.64%
Beta 2.09x
Profitable years 2
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NAGE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert N. Fried
Employees
117
Headquarters
Los Angeles
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report